U.S. SECURITIES AND EXCHANGE COMMISSION
Litigation Release No. 25886/ October 27, 2023
Securities and Exchange Commission v. Bruce Schoengood, Medifirst Solutions, Inc., and Joshua Tyrell, No. 21-civ-00979 (E.D.N.Y., filed February 23, 2021)
Final Judgment Entered Against Medifirst Solutions, Inc.
On September 25, 2023, the United States District Court for the Eastern District of New York entered a final judgment against Medifirst Solutions, Inc., a Nevada corporation with its principal office in Freehold, New Jersey.
The SEC’s Complaint, filed on February 23, 2021, alleged that Defendants Medifirst, Medifirst’s president and chief executive officer, Bruce Schoengood, and stock promoter Joshua Tyrell, engaged in a fraudulent scheme designed to evade registration requirements of the federal securities laws.
The final judgment entered against Medifirst enjoins the company from violating the antifraud provisions of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder and Section 17(a) of the Securities Act of 1933 and the registration requirements of Section 5 of the Securities Act.
The SEC appreciates the assistance of the U.S. Attorney’s Office for the Eastern District of New York.
A final judgment was entered into for Tyrell on June 16, 2022. The Commission’s case remains pending against defendant Schoengood.